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Hyperglycaemia and Pseudomonas 
aeruginosa acidify cystic fibrosis 
airway surface liquid by elevating 
epithelial monocarboxylate 
transporter 2 dependent lactate-H+ 
secretion
James Peter Garnett1,2, Kameljit K. Kalsi3, Mirko Sobotta2, Jade Bearham3, Georgina Carr1, 
Jason Powell1, Malcolm Brodlie1, Christopher Ward1, Robert Tarran4 & Deborah L. Baines3
The cystic fibrosis (CF) airway surface liquid (ASL) provides a nutrient rich environment for bacterial 
growth including elevated glucose, which together with defective bacterial killing due to aberrant 
HCO3− transport and acidic ASL, make the CF airways susceptible to colonisation by respiratory 
pathogens such as Pseudomonas aeruginosa. Approximately half of adults with CF have CF related 
diabetes (CFRD) and this is associated with increased respiratory decline. CF ASL contains elevated 
lactate concentrations and hyperglycaemia can also increase ASL lactate. We show that primary human 
bronchial epithelial (HBE) cells secrete lactate into ASL, which is elevated in hyperglycaemia. This leads 
to ASL acidification in CFHBE, which could only be mimicked in non-CF HBE following HCO3− removal. 
Hyperglycaemia-induced changes in ASL lactate and pH were exacerbated by the presence of P. 
aeruginosa and were attenuated by inhibition of monocarboxylate lactate-H+ co-transporters (MCTs) 
with AR-C155858. We conclude that hyperglycaemia and P. aeruginosa induce a metabolic shift which 
increases lactate generation and efflux into ASL via epithelial MCT2 transporters. Normal airways 
compensate for MCT-driven H+ secretion by secreting HCO3−, a process which is dysfunctional in CF 
airway epithelium leading to ASL acidification and that these processes may contribute to worsening 
respiratory disease in CFRD.
In people with cystic fibrosis (CF), the microbiocidal activity of the airway surface liquid (ASL) is defective due 
to aberrant HCO3− transport and acidic pH1–3 and there is a nutrient rich environment for bacterial growth 
including elevated concentrations of amino acids, mucins, iron and glucose4. In CF, coexisting diabetes mellitus 
(CF-related diabetes; CFRD) is associated with an increased risk of infection with multiple antibiotic-resistant P. 
aeruginosa. Patients with CFRD have more pulmonary exacerbations and respond less well to intravenous anti-
biotics, than those without diabetes5. In humans, we have shown that ASL glucose concentrations are normally 
lower than those of plasma (0.4 mM compared to 5 mM) but are elevated in patients with CF (~2 mM) and are 
further elevated in CFRD (~4 mM)6. In intubated patients on intensive care, elevated glucose concentrations in 
bronchial aspirates were associated with the presence and acquisition of respiratory pathogens7. In human airway 
epithelial cells grown at air-liquid interface, elevation of basolateral glucose concentrations increased ASL glucose 
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concentrations and promoted the growth of respiratory pathogens such as P. aeruginosa over and above the effects 
of other hallmarks of the CF ASL including acidic pH and mucus hyperviscosity8,9.
In CF sputum, lactate concentrations are also elevated, which is thought to be predominately caused by invad-
ing neutrophils10. Cellular lactate production by cancer cells in aerobic conditions (the Warburg effect) is well 
documented11. However, glycolysis progression to lactate production under aerobic conditions is a normal fea-
ture of mammalian cell metabolism, even in tissues that take up lactate from the circulation, such as the heart12. 
Therefore, it is conceivable that airway epithelial cells contribute to the elevated ASL lactate concentrations seen 
in CF and CFRD. Mammalian cells move lactate, in part, through monocarboxylate transporters (MCT) which 
co-transport lactate with H+ 13. Thus, epithelial lactate secretion would be predicted to acidify the extracellular 
fluid, a known feature of the CF ASL.
We therefore tested the hypothesis that airway epithelial lactate production and ASL lactate concentration 
was elevated in response to hyperglycaemia in CF and non-CF primary cultured human airway epithelial cells 
(HBE) and cell lines H441 and Calu-3. We determined whether epithelial lactate production contributed to the 
acidic ASL observed in CF by secretion via MCTs. In addition, due to the prevalence of P. aeruginosa infections in 
CFRD, we investigated the influence of the bacterium on epithelial lactate production and ASL pH.
Materials and Methods
Airway epithelial cell culture. Primary human bronchial epithelial (HBE) cells (non-CF and CF) 
were obtained from endobronchial brushings or extracted from explanted lungs and cultured as previously 
described14,15. HBE cells were obtained with informed written consent from all study patients and in accordance 
with approval from the Newcastle and North Tyneside Local Regional Ethics Committee (reference number 
2001/179 and 07/Q0906/47) The CF Center Tissue Core, University of North Carolina at Chapel Hill Biomedical 
Institutional Review Board (protocol #03-1396). Cells were transferred onto clear Transwell® (Costar) inserts 
(1.12 cm2 area, 0.45-μ m pore size) and grown at air-liquid-interface (ALI) to form confluent fully differentiated 
monolayers. Cells were studied 3–5 weeks post-seeding.
The human airway epithelial cell lines, Calu-3 and H441 (from ATCC), were cultured and grown on 
Transwell® inserts to form confluent differentiated monolayers as previously described9,16. Experiments were 
carried out 10–14 days post-seeding.
Airway surface liquid (ASL) glucose and lactate measurements. ASL glucose and lactate concentra-
tions were assessed by washing the apical surface with 50 μ l of Krebs salt solution and analysed using enzymatic 
glucose and lactate assay kits (Sigma, UK). ASL glucose and lactate concentrations were calculated assuming an 
original ASL volume of ~1 μ l (except Calu-3 cultures in which ASL volume was measured by pipette). Normal 
blood glucose or hyperglycaemia was modelled by applying D-glucose concentrations of 5 or 15 mM to the 
basolateral Krebs salt solution, respectively. 10 mM L-glucose (non-metabolisable stereoisomer of D-glucose) 
was added to 5 mM D-glucose solution to maintain osmotic balance between solutions. MCT1/2 inhibition 
was achieved using the specific inhibitor AR-C15585817. The presence of other functional MCT was investi-
gated using phloretin (50 μ M), a concentration known to inhibit several MCTs but not glucose uptake via GLUT 
transporters18.
Seahorse Glycolysis Stress Assay. 20,000 Calu-3 cells per well were seeded into a Seahorse XF96 plate 
and incubated at 37 °C, 5% CO2 for 48 hours. The medium was changed 24 hours prior to Seahorse experiment 
with or without 100 μ g/mL LPS. Three days post-seeding, the Seahorse Glycolysis Stress Assay was performed 
according to the manufacturer’s instructions with the injection of 5 or 15 mM Glucose. The plate layout was sep-
arated into quadrants to reduce edge effects.
For LPS experiments, viable cells were quantified after the seahorse assay using CyQuant Direct according to 
the manufacturer’s instructions. Briefly, the cells’ supernatant was partly aspirated to reach a volume of 100 μ L, 
then 100 μ L of the freshly prepared staining solution was added to the cells. After incubation for 1 h at 37 °C with-
out CO2, fluorescence was read with bottom reading mode of a standard plate reader.
FRET intracellular lactate measurements. H441 cells grown on polylysine coated coverslips (NeuVitro, 
Germany) were transiently transfected with Laconic (a kind gift of Prof P. Barros, Centro de Estudios Científicos, 
Chile19, using Lipofectamine 2000 (Thermo Fisher, UK). Cells were imaged 24–48 hours post transfection at 37 °C 
in a 95% air, 5% CO2 gassed Krebs salt solution, supplemented with glucose and/or inhibitors (as above), using 
a Zeiss LSM 510 Meta confocal microscope with a 20x Pan-Neofluar lens. Laconic is labelled with fluorophores 
mTFP and Venus and reports a reduction in FRET efficiency (%E) with lactate binding. This was measured by 
analysing the fluorescence emission of mTFP (donor) and Venus (acceptor) in a selected area within a cell after 
excitation at 458 nm. The Venus (acceptor) fluorescence within the selected area was photo bleached (> 80%) by 
excitation at 514 nm using full laser capacity and the fluorescence emission of both fluorophores re-measured. 
The FRET efficiency (%E) was then calculated. FRET ratio was measured using rapid excitation at 458 nm and 
recording emission at 475–525 nm (mTFP) and 530–600 nm (Venus) every second over a time course of 10 min-
utes. Elevation of intracellular lactate results in an increase in FRET ratio (mTFP/Venus).
MCT immunocytochemistry. Cells grown on Transwell® inserts were initially fixed with methanol:ace-
tone for 10 min at room temperature, washed with PBS followed by apical membrane biotinylation with biotin 
anti-goat IgG (1:200 dilution) and labelled with streptavidin conjugated to Alexa Fluor 594 (red) or 488 (green) 
(1:200 dilution). The apical surface was washed with PBS and cells blocked and permeabilized with 1% bovine 
serum albumin containing 0.1% Triton in Tris-buffered saline. Primary antibodies for MCT1 (sc-365501) and 
MCT4 (sc-50329), were from Santa Cruz, USA. MCT2 (ab198272) and MCT3 (ab60333), were from AbCam, UK. 
Cells were incubated with 1:100 dilution of antiserum and incubated at room temperature for 1 hour. Cells were 
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washed with PBS and the secondary antibody was added (anti-mouse Texas Red or anti-rabbit Alexa Fluor 488 
at 1:100 dilution) for 30 min at room temperature. After rinsing with PBS, Transwell® inserts were removed with 
a scalpel and mounted onto slides with Vectashield mounting medium containing 4′ ,6-diamino-2-phenylindole 
(DAPI) for nuclei staining. Images were visualised using a Zeiss LSM 510 Meta confocal microscope.
Western blotting for MCT proteins. Cells were lysed in buffer containing 20 mM Tris-HCL pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 50 mM NaF, 1 mM NaVO4, 1% w/v Triton-X, 0.5% w/v sodium deoxycholate, 0.1% w/v SDS, 1 μ 
g/ml protease inhibitor cocktail (P8340, Sigma, UK). Cells were sonicated and cell debris was removed by centrifuga-
tion at 10,000 RPM at 4 °C for 10 mins. Total protein concentration was determined by Bradford Assay and between 
30 μ g–60 μ g was electrophoresed on NuPage Novex 10% Bis-Tris Protein Gels (Invitrogen). Protein was then trans-
ferred onto polvinylidene difluoride membranes (Merck Millipore). Nonspecific reactivity was blocked in Odyssey 
Blocking Buffer (Licor, UK) diluted 1:1 in PBS for 1 h at room temperature. Blots were incubated overnight with 
primary antibodies described aboveMCT1 (1:1000 dilution), MCT2 (1:200 dilution) and MCT4 (1:1000 dilution). 
The blots were then washed in Tris-buffered saline/0.2% Tween 20 and incubated with either donkey anti-mouse 
IgG (926–3221) or donkey anti-rabbit IgG (Licor, UK) (both 1:40000 dilution) for 1 hr at room temperature. Blots 
were subsequently immunostained with a mouse monoclonal antibody to β -actin. Detection of antigen-antibody 
complexes was assessed using a Licor Odyssey western blot imaging system.
ASL pH measurements. ASL pH of Calu-3 and H441 monolayers was monitored in situ using a pH micro-
electrode (Lazar, USA). 100 μ l of Krebs salt solution was added to the apical surface of the monolayers at the start 
of the experiment to provide sufficient depth for the microelectrode to accurately measure pH. D-glucose con-
centrations of 5 or 15 mM were added the basolateral Krebs salt solution with or without inhibitors (as described 
above). To avoid addition of excess fluid, pH-sensitive dye was used to assess ASL pH across HBE and CF HBE 
monolayers: pH-sensitive pHrodo dextran (10 μ M) and pH-insensitive Alexa 647 dextran (10 μ M) were added to 
the Krebs salt solution and measured in situ on airway cultures using a Tecan Infinite M1000 plate reader at 37 °C, 
as previously described3. Due to auto-fluorescence of PA01, a pH microelectrode was used to measure ASL pH in 
bacteria-epithelia co-cultures.
Airway epithelia - Pseudomonas aeruginosa co-culture. A single colony of P. aeruginosa PA01 was 
incubated overnight at 37 °C in EMEM (containing 5 mM glucose). Bacterial cultures were diluted in glucose-free 
Krebs salt solution (as above). 1 × 106 CFU/ml PA01 was applied to the apical surface of HBE cell monolayers in 
100 μ l of solution. The basolateral side of the airway epithelial-bacterial co-cultures were washed and placed in 
Krebs salt solution 24 hours prior to co-culture experiments to remove antibiotics and components of the media 
that could influence bacterial growth. D-glucose concentrations of 5 or 15 mM were then added to the basolateral 
solution as described above. Co-cultures were placed in a CO2 incubator at 37 °C for 6 hours, after which ASL pH 
was monitored using a pH microelectrode and each was homogenised for CFU calculation by plating out serial 
dilutions on Luria agar.
Chemicals and reagents. All chemicals and reagents were obtained from Sigma, Poole, UK unless other-
wise stated.
Statistical analysis. Values are reported as mean ± S.E.M. Statistical analysis was performed using analysis 
of variance (ANOVA) and post hoc Bonferroni multiple comparison or Student’s t test. P values < 0.05 were 
considered significant.
Results
Hyperglycaemia elevates glucose and lactate concentrations in airway surface liquid under 
aerobic culture conditions. Hyperglycaemia was mimicked in airway epithelial monolayers grown at 
air liquid interface by increasing D-glucose from 5 to 15 mM in the basolateral salt solution for 6 hours. This 
resulted in a significant rise in ASL glucose concentration in non-CF HBE and CFBE consistent with previous 
results in H441 and Calu3 cells9,20 (Fig. 1A). ASL lactate concentrations were elevated in all cell types (Fig. 1B–D) 
(2.1 ± 0.7 mM to 5.7 ± 1.5 mM in non-CF HBE monolayers; 3.7 ± 0.3 mM to 8.3 ± 1.0 mM in H441; 2.2 ± 0.7 mM 
to 7.1 ± 1.2 mM in Calu-3; P < 0.05, n = 7–13).
Hyperglycaemia modifies glycolysis and elevates intracellular lactate concentrations in airway 
epithelial cells. In order to study whether hyperglycaemia induced a shift in metabolism in airway epithelial 
cells, we measured glycolysis by extracellular acidification rate (ECAR; Fig. 2A) and respiration by oxygen consump-
tion rate (OCR; Fig. 2B) in Calu-3 cells using a Seahorse Analyzer. Increasing the glucose content of the bathing 
medium from 5 to 15 mM had no significant effect on OCR, but led to a significant increase in the rate of aerobic 
glycolysis (Fig. 2C; P < 0.01; n = 12) and the glycolytic capacity of the Calu-3 cells (Fig. 2D; P < 0.0001; n = 12).
To confirm that hyperglycaemia increased intracellular lactate concentrations and thus an increased driving 
force for excretion via MCTs, H441 airway epithelial cells were transfected with the intracellular FRET sensor, 
Laconic19. Changes in intracellular lactate were analysed by independently measuring Laconic FRET efficiency 
and FRET ratio (Fig. 3A–D). Elevated basolateral glucose resulted in an increase in intracellular lactate, as evi-
denced by a decrease in FRET efficiency (P < 0.05; n = 24) and an increase in FRET ratio (P < 0.0001; n = 24).
Inhibition of monocarboxylate transporters partially prevents hyperglycaemia-induced changes 
in ASL lactate concentration. Inhibition of monocarboxylate transporter MCT1/2 with AR-C155858 
(100 nM) partially prevented the effects of hyperglycemia on ASL lactate (Fig. 1B–D; glucose-induced increase in 
lactate concentration reduced by 54% in HBE monolayers; by 47% in H441; by 54% in Calu-3; P < 0.05, n = 5–13) 
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but did not reduce ASL lactate under normoglycemic conditions (data not shown). Phloretin (50 μ M), a drug 
known to inhibit several MCTs had no additional effect on lactate concentration in the ASL (Fig. 1B).
Hyperglycaemia-induced increases in intracellular lactate in H441 cells could be further elevated by the 
addition of AR-C155858 (100 nM) + phloretin (50 μ M) resulting in a 6.45% increase in FRET ratio (Fig. 3B; 
P < 0.0001; n = 24) and 14.91% decrease in FRET efficiency (Fig. 3D; P < 0.05; n = 24), consistent with inhibition 
of lactate efflux pathways.
Airway epithelia express MCT2 and MCT4. Immunostaining revealed no expression of MCT1 in pri-
mary HBE cells and little, predominantly intracellular staining for MCT1 in H441 cells (Fig. 4A–D). MCT2 was 
clearly immunostained in western blot as a ~40 kDa protein and was present in the cell membrane, including the 
apical membrane domain of both cell types. We did not observe any staining with antiserum to MCT3 in either 
cell type (data not shown). MCT4 western blot identified proteins of ~50, ~40, and ~30 kDa and there was clear 
basolateral localisation of MCT4 in H441 and HBE with limited expression in the apical membrane.
Hyperglycaemia induces MCT-dependent ASL acidification in airway epithelial cultures lacking 
CFTR-dependent bicarbonate secretion. As lactate is co-transported with H+, MCT-dependent lactate 
secretion would be predicted to acidify the ASL. In addition to increasing ASL lactate (Fig. 1), hyperglycemia also 
decreased ASL pH in H441 cells (Fig. 5A; P < 0.01; n = 5), but produced a slight alkalinisation in ASL of Calu-3 
monolayers (Fig. 5B; P < 0.05; n = 9).
Figure 1. Hyperglycaemia increases airway surface liquid (ASL) glucose and monocarboxylate transporter 
(MCT)-dependent concentrations in primary airway epithelial cultures. (A) Glucose concentration of ASL 
from non-CF and CF primary HBE cell monolayers after 6 hours in the presence of basolateral 5 mM or 15 mM 
D-glucose. Lactate concentration of ASL from primary HBE cell (B) H441 (C) and Calu-3 (D) monolayers 
after 6 hours in the presence of basolateral 5 mM or 15 mM D-glucose in the absence or presence of 100 nM 
MCT2 inhibitor AR-C15585 (ARC) and 50 μ M phloretin (PT). ns P > 0.05, *P < 0.05, **P < 0.01, n = 5–13. Data 
represent the means ± S.E.M.
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A key difference between Calu-3 and H441 epithelial cells is that Calu-3 cells possess CFTR and pro-
duce HCO3− rich fluid secretions16. To test whether HCO3− secretion in Calu-3 cultures compensated for 
lactate-driven H+ secretion, hyperglycaemia-induced changes in Calu-3 ASL pH were measured in cultures in 
Figure 2. Hyperglycaemia induces a metabolic shift in airway epithelia towards aerobic glycolysis.  
(A) ECAR measurement trace and (B) OCAR measurement trace during Seahorse Glycolysis Stress Assay 
in which the medium bathing the Calu-3 cells was injected with of 5 or 15 mM Glucose, 1 μ M Oligomycin 
and 75 mM Oligomycin. (C) Glycolysis rate, calculated by subtracting the normalized ECAR values after 
2-Deoxy-D-Glucose (2-DG) injection from the ECAR values after glucose injection, in order to exclude the 
non-glycolytic acidification from the calculation. (D) Glycolytic capacity, calculated by subtracting the non-
glycolytic acidification rate (ECAR after 2-DG injection) from the maximum ECAR after 1 μ M Oligomycin 
injection. **P < 0.01, ****P < 0.0001, n = 12. Data represent the means ± S.E.M.
www.nature.com/scientificreports/
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which HCO3− secretion was limited by removing HCO3− from the bathing solution and replacing with HEPES. 
Under these conditions Calu-3 ASL acidified under hyperglycaemic conditions (Fig. 5B; P < 0.05; n = 9).
Hyperglycaemia-induced ASL acidification was also observed in primary HBE monolayers from CF patients 
(Fig. 5C; P < 0.05; n = 5), but not in non-CF HBE (Fig. 5C; P < 0.05; n = 5). Critically, inhibition of monocar-
boxylate transporter MCT2 with AR-C155858 (100 nM) significantly attenuated the hyperglycaemia-induced 
acidification of CF ASL.
Pseudomonas aeruginosa enhances the hyperglycaemia-induced acidification of ASL pH across 
cystic fibrosis airway epithelial cultures. Next we investigated how the airway epithelium responded to 
the addition of P. aeruginosa (PA01) and whether this response was altered in CF HBE cultures with and without 
hyperglycaemia. P. aeruginosa did not affect fluid pH in the absence of epithelial cells after 6 hours of growth 
(Fig. 6A; P > 0.05; n = 6; compared to solution pH = 7.4). The addition of P. aeruginosa (from 105–107 CFU) to 
the apical surface of non-CF HBE cells also had no effect on ASL pH (Fig. 6A; P > 0.05; n = 6). However, ASL 
from CF HBE cells became more acidic after the addition of 106 CFU P. aeruginosa (decreased by 0.25 ± 0.02 pH 
units after 6 hours; Fig. 6B; P < 0.05; n = 5). This P. aeruginosa-induced acidification was enhanced by increasing 
basolateral glucose from 5 to 15 mM (42 ± 14% increase; Fig. 6B; P < 0.05; n = 5).
P. aeruginosa-induced ASL acidification could be replicated in non-CF HBE by replacing HCO3− 
with a HEPES-buffered bathing solution to limit HCO3− secretion. This was confirmed by the loss of 
forskolin-stimulated HCO3− secretion and ASL alkalisation in HEPES buffered but not HCO3− buffered cells 
(Fig. 6C). Increasing basolateral glucose also led to a greater ASL acidification of PA01 infected non-CF HBE 
cells in the presence of HEPES (Fig. 6D; P < 0.05; n = 5). Furthermore, replacing HCO3− with HEPES increased 
P. aeruginosa growth/survival, which was further enhanced by raising the glucose concentration in the bathing 
solution (Fig. 6E; P < 0.01; n = 5).
To investigate whether P. aeruginosa may induce changes in ASL pH through shifts in metabolism similar to 
those observed with hyperglycaemia, Calu-3 cells were exposed to LPS from P. aeruginosa and changes in metab-
olism (ECAR) were measured using a Seahorse Analyzer. LPS enhanced both aerobic glycolysis (Fig. 7A; P < 0.05; 
Figure 3. Hyperglycaemia induces an increase in intracellular lactate concentration. Changes in 
intracellular lactate concentrations induced by increasing extracellular D-glucose from 5 to 15 mM with and 
without 100 nM AR-C155858 (ARC) or 50 μ M phloretin (PT) measured using a lactate FRET sensor (Laconic) 
expressed in H441 cells. (A) Fluorescence images of mTFP (blue), Venus (yellow) and merged images in 
cells before and after photobleach. (B) Calculated FRET efficiency (%E). (C) FRET ratio (mTFP/Venus) in 
an exemplar H441 cell, over time course of treatments. (D) Collated FRET ratio data *P < 0.05, **P < 0.01, 
***P < 0.001, n = 24. Data represent the means ± S.E.M.
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n = 11) and the glycolytic capacity (Fig. 7B; P < 0.01; n = 11) of the airway epithelial cells under normoglycaemic 
and hyperglycaemic conditions.
Pseudomonas aeruginosa-induced changes in ASL lactate and pH across cystic fibrosis airway 
epithelial cultures can be overcome by MCT inhibition. P. aeruginosa-induced acidification of CF 
ASL was attenuated in the presence of the MCT2 inhibitor AR-C155858 (Fig. 8A; P < 0.05; n = 5). PA01 did not 
produce lactate in isolated culture (data not shown), indicating that the bacterium induced these changes in CF 
Figure 4. Airway epithelia express monocarboxylate transporters (MCT) 2 & 4. Western blot and confocal 
images of immunostained MCT in H441 (A,B) and HBE (C,D) cells grown on Transwell supports. (A,C) 
Western blots of MCT1 (not detected in HBE), 2 and 4 (red) and β -actin (green). (B,D) XY planes (centre) and 
XZ planes to the top and right (H441 only); apical surface indicated by an arrow; biotin-conjugated fluorophore 
labelling of the apical surface (red) (H441 only), MCT1, 2 and 4 (green) or absence of primary antiserum  
(no MCT control), DAPI stained nuclei (blue).
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Figure 5. Hyperglycaemia induces MCT-dependent ASL acidification in airway epithelial cultures lacking 
CFTR-dependent bicarbonate secretion. (A) H441 ASL pH after 6 hours in 5 or 15 mM basolateral D-glucose, 
in the absence or presence of 100 nM MCT2 inhibitor AR-C155858 (ARC) *P < 0.05, **P < 0.01, n = 5.  
(B) Calu-3 ASL pH after 6 hours in HCO3− or HEPES-buffered basolateral salt solution containing 5 or 15 mM 
D-glucose, in the absence or presence of 100 nM AR-C155858 (ARC) *P < 0.05, n = 9. (C) HBE or CF HBE ASL 
pH after 6 hours in 5 or 15 mM basolateral D-glucose, in the absence or presence of 100 nM AR-C155858 (ARC) 
*P < 0.05, n = 5. Data represent the means ± S.E.M.
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Figure 6. P. aeruginosa further acidifies airway ASL and enhances bacterial growth in the absence of CFTR-
dependent bicarbonate secretion. (A) pH of HBE ASL after 6 hours in basolateral salt solution containing 
5 mM D-glucose (HBE only) or in the presence of apical P. aeruginosa PA01 (+ 1 × 105–107 CFU), or pH of 
fluid from bacterial culture in the absence of HBE cells (1 × 107 CFU PA01 only) n = 6. B. CF HBE ASL pH 
after 6 hours in the absence (CF HBE only) and presence of 1 × 106 CFU apical PA01 (+ PAO1), in basolateral 
HCO3−-buffered salt solution containing 5 or 15 mM D-glucose. (C) HBE ASL pH after 6 hours in the absence 
(open bars) or presence (black bars) of 1 × 106 CFU apical PA01 (+ PA01) in basolateral HCO3− or HEPES-
buffered salt solution containing 5 mM D-glucose with or without 5 μ M forskolin (FSK) *P < 0.05, **P < 0.01, 
n = 5. D. HBE ASL pH after 6 hours in HCO3− or HEPES-buffered basolateral salt solution containing 5 or 
15 mM D-glucose in the presence of 1 × 106 CFU apical PA01 *P < 0.05, **P < 0.01, n = 5. E. P. aeruginosa CFU 
on the apical surface of HBE monolayers after 6 hours in HCO3− or HEPES-buffered basolateral salt solution 
containing 5 or 15 mM D-glucose *P < 0.05, **P < 0.01, n = 5. Data represent the means ± S.E.M.
www.nature.com/scientificreports/
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ASL pH by stimulating epithelial lactate secretion. Consistent with this hypothesis, we found that ASL lactate pro-
duction increased from 3.3 ± 0.7 mM to 14.9 ± 4.1 mM following the addition of P. aeruginosa (P < 0.05; n = 5), 
which could be significantly reduced by MCT2 inhibition (Fig. 8B; P < 0.05; n = 5).
Discussion
Our data provide the first evidence that lactate is present in the ASL of human bronchial epithelial cells and that 
lactate concentration increased in ASL under hyperglycaemic culture conditions. We show that hyperglycaemia 
induced a metabolic shift towards aerobic glycolysis and increased intracellular lactate production. Our data also 
demonstrate a new role for MCT2 in mediating epithelial lactate efflux in airway cells in response to hypergly-
caemia. During hyperglycaemic challenge of cells grown at air-liquid interface, apical application of the MCT1/2 
specific inhibitor AR-C155858 reduced lactate in ASL but the general MCT inhibitor phloretin did not evoke 
any additional effect. In non-polarised cells phloretin but not AR-C155858 elevated intracellular lactate. Thus, 
these data point to the differential expression of transporters in polarised airway epithelial cells. In support of this 
notion, we demonstrated the presence of MCT2 on the apical surface and MCT4 on the basolateral surface of 
polarised epithelial cells. Thus, the apical localisation of MCT2 and action of AR-C155858 indicated that it medi-
ated secretion of lactate into ASL. The basolateral localisation of MCT4 and lack of effect of apically applied PT in 
polarised cells (but not in non-polarised cells) indicated that MCT4 may sub serve another function. As lactate 
can also move across cell membranes via other pathways21, the incomplete inhibition of lactate secretion into the 
ASL by AR-C155858 would support other routes for lactate movement out of the cell and into ASL.
We did not detect MCT1 or MCT3 in human airway epithelial cells. MCT1 and 4 have previously been 
described in the developing rat and human airway22. However, the expression of MCT1 declined as the lungs 
developed from the pseudoglandular to saccular phase indicating that, consistent with our observations, MCT1 
is unlikely to be present in adult cells22.
Mucosal addition of P. aeruginosa to airway epithelia increased epithelial lactate concentration in ASL. We 
previously demonstrated that airway epithelial glucose uptake was elevated in the presence of P. aeruginosa and 
pro-inflammatory stimuli9,23. Like hyperglycaemia (which increases the diffusion gradient for facilitative glucose 
uptake), increased glucose transport is also likely to drive a metabolic shift to increase cellular lactate production 
Figure 7. LPS increases the rate of aerobic glycolysis in airway epithelial cells. (A) Glycolysis rate of LPS-
treated Calu-3 cells (24 hours pre-treatment), calculated by subtracting the normalized ECAR values after 
2-Deoxy-D-Glucose (2-DG) injection from the ECAR values after glucose injection, in order to exclude the 
non-glycolytic acidification from the calculation. (B) Glycolytic capacity of LPS-treated Calu-3 cells (24 hours 
pre-treatment), calculated by subtracting the non-glycolytic acidification rate (ECAR after 2-DG injection) 
from the maximum ECAR after 1 μ M Oligomycin injection. *P < 0.05, **P < 0.01, n = 11. Data represent the 
means ± S.E.M.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:37955 | DOI: 10.1038/srep37955
and secretion. We show that pro-inflammatory stimuli do indeed drive a metabolic shift towards enhanced aer-
obic glycolysis and increased lactate production. Moreover, increased uptake in the presence of hyperglycaemia 
would be expected to elevate lactate secretion even further, consistent with our results. In vivo, in the absence of, 
or prior to an inflammatory response, inducing such changes in host metabolism to elevate lactate in ASL may 
favour P. aeruginosa growth over other bacteria present in the airway microbiome as fewer species can utilise lac-
tate as a growth source24. Moreover, these effects are likely to be exacerbated in the viscous mucus of the CF ASL25.
It is well established in CF that a lack of functional CFTR impairs airway HCO3− and fluid secretion producing 
an acidic, viscous ASL1,16,26 that is readily colonised by bacteria such as P. aeruginosa. The acidity of the ASL leads 
to impaired activity of antimicrobial peptides and microbicidal effect in animal models of CF lung infections2. 
Our results indicate that the airway epithelium secretes HCO3− which neutralises the acidifying effect of lactate 
secretion to maintain optimal ASL pH. Moreover, we show that this process is impaired in CF epithelium lead-
ing to acidification of ASL. Recently a transporter has been identified (ATP12A) which mediates H+ secretion 
in human airways but is absent in the mouse27. Our data indicate that acidification of ASL can also occur by 
MCT-driven H+ secretion when the epithelium is challenged with bacteria and/or during hyperglycaemia. Thus, 
these data further support the critical role of CFTR in the regulation of HCO3− secretion and identify new key 
processes contributing to the acidic ASL of the CF lung.
Development of CFRD is associated with increased colonisation by P. aeruginosa and poorer outcomes5,28,29. 
We previously demonstrated that hyperglycaemia elevated ASL glucose and increased the growth/survival of P. 
Figure 8. P. aeruginosa induces MCT-dependent elevation of lactate and ASL acidification in CFBE. (A) 
CF HBE ASL pH and G. ASL Lactate concentration after 6 hours in HCO3−-buffered basolateral salt solution 
containing 5 mM D-glucose in the absence (CF HBE only) or presence of 1 × 106 CFU apical PA01 (+ PA01), or 
100 nM MCT2 inhibitor AR-C155858 (ARC). *P < 0.05, **P < 0.01, n = 5. Data represent the means ± S.E.M.
www.nature.com/scientificreports/
1 2Scientific RepoRts | 6:37955 | DOI: 10.1038/srep37955
aeruginosa9. Together with our current observations we propose that during CFRD, hyperglycaemia enhances 
bacterial colonisation of the ASL by providing a richer nutrient source (glucose and lactate) and a reduced pH 
which impair bacterial killing and favour growth. Our data are consistent with a critical role for CFTR-dependent 
bicarbonate secretion and ASL glucose homeostasis in airway innate immunity and the suppression of pathogen 
growth.
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